Barclays Maintains Equal-Weight on Alignment Healthcare, Lowers Price Target to $9
Benzinga Newsdesk 4 days ago
Analyst RatingsNewsPrice Target
Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and lowers the price target from $10 to $9.
Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and lowers the price target from $10 to $9.